Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma

Duo Xu; Yanyun Gao; Shengchen Liu; Shiyuan Yin; Tong Hu; Haibin Deng; Tuo Zhang; Balazs Hegedüs; Thomas M. Marti; Patrick Dorn; Shun Qing Liang; Ralph A. Schmid; Ren Wang Peng; Yongqian Shu

doi:10.1038/s44321-025-00366-5

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma

Duo Xu
, Yanyun Gao
, Shengchen Liu
, Shiyuan Yin
, Tong Hu
, Haibin Deng
, Tuo Zhang
, Balazs Hegedüs
, Thomas M. Marti
, Patrick Dorn
, Shun Qing Liang
, Ralph A. Schmid
, Ren Wang Peng
, Yongqian Shu

Medicine - Gastro, Hepatology, Nutrition Division

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors notified the journal after finding an error in one of the figure panels. After reviewing the supplied source data the journal agrees to withdraw and replace Fig. EV1C.

Original language	English (US)
Pages (from-to)	851-854
Number of pages	4
Journal	EMBO Molecular Medicine
Volume	18
Issue number	2
DOIs	https://doi.org/10.1038/s44321-025-00366-5
State	Published - Feb 13 2026

Bibliographical note

Publisher Copyright:
© 2026 The Author(s).

PubMed: MeSH publication types

Published Erratum

Publisher link

10.1038/s44321-025-00366-5

Find It

Find It at U of M Libraries

Cite this

@article{61ff07cc7c984a0bb074e4b3604c488a,

title = "Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma",

abstract = "The authors notified the journal after finding an error in one of the figure panels. After reviewing the supplied source data the journal agrees to withdraw and replace Fig. EV1C.",

author = "Duo Xu and Yanyun Gao and Shengchen Liu and Shiyuan Yin and Tong Hu and Haibin Deng and Tuo Zhang and Balazs Heged{\"u}s and Marti, \{Thomas M.\} and Patrick Dorn and Liang, \{Shun Qing\} and Schmid, \{Ralph A.\} and Peng, \{Ren Wang\} and Yongqian Shu",

note = "Publisher Copyright: {\textcopyright} 2026 The Author(s).",

year = "2026",

month = feb,

day = "13",

doi = "10.1038/s44321-025-00366-5",

language = "English (US)",

volume = "18",

pages = "851--854",

journal = "EMBO Molecular Medicine",

issn = "1757-4676",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "2",

}

TY - JOUR

T1 - Correction to

T2 - De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma

AU - Xu, Duo

AU - Gao, Yanyun

AU - Liu, Shengchen

AU - Yin, Shiyuan

AU - Hu, Tong

AU - Deng, Haibin

AU - Zhang, Tuo

AU - Hegedüs, Balazs

AU - Marti, Thomas M.

AU - Dorn, Patrick

AU - Liang, Shun Qing

AU - Schmid, Ralph A.

AU - Peng, Ren Wang

AU - Shu, Yongqian

PY - 2026/2/13

Y1 - 2026/2/13

N2 - The authors notified the journal after finding an error in one of the figure panels. After reviewing the supplied source data the journal agrees to withdraw and replace Fig. EV1C.

AB - The authors notified the journal after finding an error in one of the figure panels. After reviewing the supplied source data the journal agrees to withdraw and replace Fig. EV1C.

UR - https://www.scopus.com/pages/publications/105027744163

UR - https://www.scopus.com/pages/publications/105027744163#tab=citedBy

U2 - 10.1038/s44321-025-00366-5

DO - 10.1038/s44321-025-00366-5

M3 - Comment/debate

C2 - 41545767

AN - SCOPUS:105027744163

SN - 1757-4676

VL - 18

SP - 851

EP - 854

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

IS - 2

ER -

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma

Abstract

Bibliographical note

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Fingerprint

Cite this